40 results
425
PYXS
Pyxis Oncology Inc
11 Aug 23
Business combination disclosure
6:35am
, Apexigen approved a retention plan in connection with the corporate restructuring in order to retain certain employees required to explore strategic … alternatives and maintain operations as it explores those strategic alternatives. These employees were granted cash retention bonuses, which will become
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
with the signing of the Merger Agreement and closing of the Merger, Mr. Sarena, Mr. Duke, and Ms. Wong are eligible for payment of a retention cash … award and vesting of restricted stock units pursuant to retention awards granted by Apexigen;
In connection with the closing of the Merger, Dr. Yang
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
with the filing of relevant Tax Returns, and any Proceeding related Taxes. Such cooperation shall include the retention and (upon the other party’s … , mortgage, pledge, reservation, equitable interest, adverse claim, charge, easement, lease, sublease, conditional sale or other title retention
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
with the filing of relevant Tax Returns, and any Proceeding related Taxes. Such cooperation shall include the retention and (upon the other party’s request … , mortgage, pledge, reservation, equitable interest, adverse claim, charge, easement, lease, sublease, conditional sale or other title retention agreement
424B3
helh0t4 it8c3ngr
10 Apr 23
Prospectus supplement
4:03pm
424B3
veh0h
10 Apr 23
Prospectus supplement
4:02pm
POS AM
n9urk2gk9
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
xsm36h ny
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
fo3invh zj8ex3
9 Sep 22
Prospectus supplement
4:40pm
424B3
xgk96y1k x7
9 Sep 22
Prospectus supplement
4:38pm